Clinical observation of chemotherapy combined with autologous cytokine-induced killer cells and dendritic cells for advanced gastric cancer

Medical Journal of Chinese People's Liberation Army

Volumn 40, Issue 6, 2015, Pages 475-478

  Lv, Gang ^a   Zhang, Qing Jun ^a   Shi, Yu Qi ^a   Cao, Zhi Yu ^a  

^a 309TH HOSPITAL OF PLA   (China)

Author keywords

Antineoplastic combined chemotherapy protocols; Cytokine induced killer cells; Dendritic cells; Stomach neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; FOLFOX 4; UNCLASSIFIED DRUG;

ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER IMMUNOTHERAPY; CD4 CD8 RATIO; CELLULAR IMMUNITY; CYTOKINE INDUCED KILLER CELL; DENDRITIC CELL; FOLLOW UP; HUMAN; INJECTION; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; PATIENT SAFETY; QUALITY OF LIFE; STOMACH CANCER; SURVIVAL RATE; TRANSFUSION; TUMOR VOLUME;

EID: 84933528061     PISSN: 05777402     EISSN: None     Source Type: Journal    
DOI: 10.11855/j.issn.0577-7402.2015.06.11     Document Type: Article

References (16)

1. [1] Li XM, Sun S, Wang JG, et al. CIK cells induced apoptosis of MGC2803 gastric cancer cell lines[J]. Pract Oncol J, 2004, 18 (6): 413 - 416.
2. [2] He G, Yang T, Zhang S. The immune index changes of metastatic malignant tumor cell with autologous CIK doping[J]. Pract Oncol J, 2014, 29(1): 32-34.
3. [3] Shu X, Li X, Wang ZY. The present research situation and progress of CIK cells in gastric cancer therapy[J]. Armed Police Med J, 2013, 24(6): 433-435.
4. [4] Jongmans W, Tiemessen DM, van V lodrop I J, et al. Th1-polarizing capacity of clinical grade dendritic cells is triggered by Ribomunyl but is compromised by PGE2: the impotence of maturation cooktails[J]. J Immunother, 2005, 28(5): 480-487.
5. [5] Tuo S, Zhang NS, Zhang N, et al. Inhibitory effect of dendritic cells plus c y tokine induced killer cells on the grow th and postoperative recurrence and metas tasis of primar y liver lymphoma[J]. Med J Chin PLA, 2010, 35(12): 1449-1454.
6. [6] Zhou YY, Jiang JT. Cytokines in the role of CIK cells anti-tumor treatmen[J]. J Clin Inspect, 2014, 33(2): 161-163.
7. [7] Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status[J]. Cancer, 1980, 45(8): 2220-2224.
8. [8] Jiang J, Xu N, Wu C, Deng H,. Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells[J]. Anticancer Res, 2006, 26(3B): 2237-2242.
9. [9] Zhang Y, Liu JB, Yang L. Clinical estimtation of effects on chemotherapy combined with CIK for patients with advanced gastric cancer[J]. J Basic Clin Oncol, 2009, 22(4): 347-348.
10. [10] Gong JX, Liu JQ, Li X,. Clinical observation of co-treatment with CIK cells and dendritic cells for postoperative advanced gastric cancer[J]. Chin J Clin Oncol, 2007, 33(14): 803-806.
11. [11] Zhao J, Xiao KY, Li X,. Treatment of malignant tumor with CIK cells: 3 cases of hepatitis C virus and literature review[J]. J Shandong Univ (Health Sci), 2014, 52(8): 108-110, 112.
12. [12] Meng X, Li PH, Li ZX. CIK cells from cord blood lymphocyte subtypes changes before and after treatment in patients with gastric cancer[J]. Pract Med J, 2014, 30(13): 915-917.
13. [13] Yang B, Cai LL, Wang HT,. Treatment of an elderly patient with acute myelocytic leukemia transformed from myelodysplastic syndrome with decitabine in ultra-low dosage combining with transfusion of autologous cytokine-induced killer cells: a case report and review of literature[J]. Med J Chin PLA, 2014, 39(4): 315-319.
14. + T cells to Fas-mediated apoptosis[J]. Cancer Immunol Immunother, 2000, 49(6): 335-345.
15. [15] He LX, Jiang SQ, Peng DW. The research progress of DC-CIK treatment of malignant tumor[J]. Med Rev, 2013, 19(1): 59-61.
16. [16] Pang C, Zhang TY, Wang CL. Effect of Tumor Stem Cell Derived CSC-DC-CIK on Destructing Homologous Tumor Cells[J]. Tianjin Med J, 2014, 42(10): 972-976.